Semaglutide

A GLP-1 receptor agonist with a long half-life, studied across metabolic and weight-management research.

What it is

Semaglutide is a GLP-1 receptor agonist engineered for an extended half-life, which enables once-weekly research dosing. It is one of the best-established single-pathway incretin compounds and a common baseline for the dual and triple agonists studied alongside it.

What the research looks at

In research models, semaglutide is studied for metabolic, cardiovascular and weight-management research through GLP-1 receptor signalling. Its long half-life, the feature that supports once-weekly research dosing, is itself a frequent subject of investigation into incretin pharmacokinetics.

Supplied strictly for laboratory research use only, not for human or veterinary use.

At a glance

Preparing it

Reconstitute the lyophilized powder with bacteriostatic or sterile water, added slowly down the side of the vial and swirled gently, never shaken, until fully dissolved. The volume of water you add sets the concentration of the solution.

For the full procedure see reconstitution, and to work out concentration per unit see concentration & math.

Where to go next